Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the…
Burn Blend Releases Comprehensive Gelatin Trick Recipe Based Protocol Guide in Response to Rising Public Interest in Weight-Management Methods
New York City, NY, Nov. 23, 2025 (GLOBE NEWSWIRE) -- Â The organization…
Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today issued the following statement in response…
Canadian Red Cross sending emergency medical clinic to Jamaica
Humanitarian experts deploying to help people impacted by Hurricane Melissa November 10,…
In Response to a Broader FDA Investigation, ByHeart Initiates a Voluntary Recall of Two Batches of Infant Formula
NEW YORK--(BUSINESS WIRE)--ByHeart, a next-generation baby nutrition company, announced today that, out…
ECW Announces US$2 Million Grant for Flood-Affected Children in Pakistan
First Emergency Response grant will reach 34,483 students through local consortium led…
Miggo Security Receives Frost & Sullivan’s 2025 Global New Product Innovation Recognition for Advancing Application Security Leadership
The company is redefining application security and AI Runtime Protection through its…
Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the…
Ibottas Thanksgiving on Us Sets the Table for the Season for the Sixth Consecutive Year
In addition to cash back on Thanksgiving staples, Ibotta is donating $50,000…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…